JP Morgan Chase & Co’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.63M | Buy |
|
|||||
|
2025
Q2 | $990K | Sell |
|
|||||
|
2025
Q1 | $908K | Buy |
|
|||||
|
2024
Q4 | $1.17M | Sell |
|
|||||
|
2024
Q3 | $1.51M | Buy |
|
|||||
|
2024
Q2 | $1.59M | Buy |
|
|||||
|
2024
Q1 | $899K | Buy |
|
|||||
|
2023
Q4 | $681K | Sell |
|
|||||
|
2023
Q3 | $4.66M | Buy |
|
|||||
|
2023
Q2 | $5.48M | Sell |
|
|||||
|
2023
Q1 | $3.28M | Buy |
|
|||||
|
2022
Q4 | $176K | Sell |
|
|||||
|
2022
Q3 | $135K | Buy |
|
|||||
|
2022
Q2 | $60K | Sell |
|
|||||
|
2022
Q1 | $202K | Buy |
|
|||||
|
2021
Q4 | $225K | Sell |
|
|||||
|
2021
Q3 | $2.43M | Buy |
|
|||||
|
2021
Q2 | $1.4M | Sell |
|
|||||
|
2021
Q1 | $2.74M | Sell |
|
|||||
|
2020
Q4 | $3.09M | Buy |
|
|||||
|
2020
Q3 | $1.7M | Sell |
|
|||||
|
2020
Q2 | $2.82M | Buy |
|
|||||
|
2020
Q1 | $180K | Hold |
|
|||||
|
2019
Q4 | $171K | Hold |
|
|||||
|
2019
Q3 | $94K | Hold |
|
|||||
|
2019
Q2 | $64K | Buy |
|
|||||
|
2019
Q1 | $7K | Hold |
|
|||||
|
2018
Q4 | $12K | Hold |
|
|||||
|
2018
Q3 | $21K | Sell |
|
|||||
|
2018
Q2 | $833K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $15K | Sell |
|
|||||
|
2017
Q3 | $329K | Sell |
|
|||||
|
2017
Q2 | $733K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $7K | Buy |
|
|||||
|
2016
Q3 | $0 | Sell |
|
|||||
|
2016
Q2 | $1K | Sell |
|
|||||
|
2016
Q1 | $3.5M | Buy |
|
|||||
|
2015
Q4 | $3.5M | Buy |
|
|||||
|
2015
Q3 | $4.49M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $18.3M | Sell |
|
|||||
|
2014
Q2 | $20M | Sell |
|
|||||
|
2014
Q1 | $20.3M | Buy |
|